CA-CEPTON-TECHNOLOGIES
1.3.2022 15:02:47 CET | Business Wire | Press release
Silicon Valley-based smart lidar solution provider Cepton, Inc. (Nasdaq: CPTN) (“Cepton”) and Fibre Based Integrations , an established fiber optics systems house, are working together to develop lidar-based vehicle detection solutions in Cape Town, South Africa, to enable smart transportation infrastructure city-wide.
This joint effort combines Fibre Based Integrations’ expertise in optics system integration and Cepton’s innovative lidar technologies to help the City of Cape Town monitor lane usage and identify vehicles using incorrect lanes. Fibre Based Integrations has deployed vehicle classification systems on traffic lights at intersections and overhead devices that utilize Cepton’s Helius® Smart Lidar System with Vista®-P lidar sensors .
Many of Cape Town’s roads have designated bus lanes to ensure the efficiency of public transportation, and Fibre Based Integrations’ lidar-enabled systems will allow the city technology department to gather highly accurate, real-time lane usage data to enable analytics that help identify ways to improve traffic flow and safety for motorists and pedestrians.
By utilizing lidar’s outstanding perception capabilities, the systems can provide useful information such as vehicle size, traffic volume, frequency, lane positioning and potential obstructions. Based on this information, system operators can gain valuable insight about how a specific intersection or piece of road is being used – including unauthorized vehicle types in designated bus lanes, peak traffic time windows, real-time lane occupancy status, wait time at traffic lights and accident-prone areas.
Josh Goosen, System Engineer at Fibre Based Integrations, said: “The reason we chose to deploy lidars in our vehicle detection and classification systems is their superior accuracy. We have previously tested radars and some other types of sensors, and we found that they lack the resolution needed to accurately locate and count vehicles and provide accurate 3D information about their sizes and speeds.
We found Cepton lidars to be the best performing and most accurate compared with others we tested, and this has unlocked new possibilities for implementing our smart city solutions with the City of Cape Town.”
Lidar technology has come to play an increasingly important role in the smart cities sector. It brings a higher level of accuracy and efficiency to existing sensor technologies to help the overall system eliminate detection errors. Lidars offer a much higher spatial resolution than radars, and perform better than cameras in various weather and lighting conditions to provide high-accuracy data 24/7. Lidars also help protect people’s privacy as they do not capture biometric information , making them suitable in venues where cameras might raise privacy concerns. The addition of lidars to smart city applications helps effectively reduce false negatives and false positives, while making systems more data efficient.
Cepton’s lidars use a patented imaging technology called Micro Motion Technology (MMT®) to help system integrators maximize the benefit of the lidar technology. The rotation-free, mirrorless and frictionless MMT design makes Cepton lidars reliable, rugged and compact, which in turn offers ease of integration and affordability for scalable applications.
In the solutions deployed by Fibre Based Integrations, Cepton’s Vista-P lidar sensors are interconnected through the Helius perception software, creating a network of smart lidar sensors to offer real-time detection, tracking and classification of vehicles and pedestrians. This enables extendable smart transportation infrastructure that collects and analyzes traffic data from different locations, while helping optimize its overall bandwidth allocation, as lidars output only a fragment of the data volume output from video camera-based alternatives.
Fibre Based Integrations and City of Cape Town are also exploring using Cepton’s lidars to augment the city’s analog and video systems with an additional layer of functionality and performance. The aim is to blend human and vehicle classification, enabled by lidar, with an AI platform to understand how both interact with the city environment. This will help collect useful information for traffic management and urban planning through machine learning, while minimizing disruption to people’s daily lives.
Klaus Wagner, Director of Product Management and Marketing at Cepton, added: “If our cities are to become smarter, then plug and play solutions like the ones we have created with Fibre Based Integrations must play a vital role in helping them do so.
Lidar has the ability to make people’s everyday lives easier even without them being fully aware of it, and that is what makes smart transport systems so intelligent. We look forward to continuing our work with Fibre Based Integrations in our effort to make Cape Town and other cities in South Africa safer. We also believe that by enabling a higher level of traffic efficiency, we can help cities build a greener environment.”
About Cepton, Inc.
Cepton is a Silicon Valley innovator of lidar-based solutions for automotive (ADAS/AV), smart cities , smart spaces and smart industrial applications. With its patented Micro Motion Technology (MMT®), Cepton aims to take lidar mainstream and achieve its vision of safe and autonomous transportation for everyone.
Cepton has been awarded the largest known ADAS lidar series production award in the industry to date, based on the number of vehicle models awarded, to support General Motors’ Ultra Cruise program. Cepton is also engaged with all other Top 10 global OEMs.
Founded in 2016 and led by industry veterans with decades of collective experience across a wide range of advanced lidar and imaging technologies, Cepton is focused on the mass market commercialization of high performance, high quality lidar solutions. Cepton is headquartered in San Jose, CA and has a center of excellence facility in Troy, MI to provide local support to the OEM and Tier 1-studded Metro Detroit area. Cepton also has a presence in Germany, Canada, Japan, India and China to serve a fast-growing global customer base. For more information, visit www.cepton.com and follow Cepton on Twitter and LinkedIn .
About Fibre Based Integrations
Fibre Based Integrations is an established fibre optic systems house serving major project houses and end users in the Telecommunications, CCTV, Process and Datacomms industry.
Our success in attracting business from our customers is as a result of our commitment to supply a total turnkey solution and to maintain a general quality standard that permeates all aspects of the project, from documentation to all the components and the optical line terminating equipment used.
As a result of years of experience gained in the field of fibre installation and integration, our highly skilled installation staff is the foundation on which the company is built. To enable Fibre Based Integrations to work to the most exacting standards, the installation teams are backed by the latest state of the art fusion splicing machines, OTDR testing equipment and installation equipment. All commissioning activities are conducted to fully documented procedures, which form an intrinsic part of the final hand-over.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220301005010/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 20:00:00 CET | Press release
Phase 3 data from the STOP-HS program demonstrate povorcitinib’s substantial and durable clinical efficacy through Week 54 in patients with moderate to severe hidradenitis suppurativa (HS). Through Week 54, clinically meaningful and durable responses were observed across all groups in both STOP-HS1 and STOP-HS2, with up to 71.4% of patients achieving HiSCR50. Improvements in clinical responses across high stringent thresholds were observed, with up to 57% of participants achieving HiSCR75 and up to 29% of participants achieving HiSCR100. Povorcitinib treatment led to consistent reductions across key inflammatory lesion types, with full resolution (ANdT=0) achieved in up to 20% of patients. Additionally, clinically meaningful improvements in quality-of-life measures, including skin pain and fatigue, were observed at Week 54. The overall safety profile of povorcitinib through 54 weeks is consistent with previously reported data, and both doses were well tolerated. Incyte (Nasdaq:INCY) to
Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 20:00:00 CET | Press release
About 70% of patients treated with zasocitinib achieved clear or almost clear skin (sPGA 0/1) at week 16 in Phase 3 plaque psoriasis studies A significantly greater PASI 75 response rate versus placebo was observed as early as week 4 Safety profile consistent with Phase 2b studies with no new safety signals identified Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham,
AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 16:00:00 CET | Press release
Pharmacokinetics, safety and efficacy clinical study data show that nemolizumab achieved clinically meaningful reductions in skin lesions and itch through Week 16, which were sustained up to a year in children aged 2 to 11 with moderate-to-severe atopic dermatitis1 These findings reinforce the previously established safety and efficacy of nemolizumab in adults and adolescents with moderate-to-severe atopic dermatitis, for which it is approved by multiple global regulatory authorities2,3 Up to 25% of children are affected by atopic dermatitis, and currently there are limited approved treatment options for children living with moderate-to-severe atopic dermatitis4,5 Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-break
Angelalign Technology (6699.HK)Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 20:56:00 CET | Press release
Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti
Axway Positioned as a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment27.3.2026 18:46:00 CET | Press release
Axway, a 74Software company (Euronext: 74SW) and global leader in federated API management and enterprise integration, has been named a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment.1 Axway Amplify securely connects, orchestrates, and automates data integration. Organizations in financial services, manufacturing, healthcare, and other industries rely on Amplify to modernize integrations and confidently unlock data to deliver superior digital services faster. The report notes: “The platform benefits from Axway’s long-standing experience in B2B integration, secure file transfer, and legacy connectivity, providing differentiated capabilities for organizations that need to expose and control APIs around core systems that are not cloud-native.”1 This multi-pattern expertise in security, integration, and federated governance — built during the early phases of the API-driven digital transformation — becomes especially critical as enterprises seek to govern dat
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom